Q4 2021 Taysha Gene Therapies Inc Earnings Call Transcript
Welcome to the Taysha Gene Therapies Fourth Quarter and Full Year 2021 Financial Results and Corporate Update. (Operator Instructions)
As a reminder, this call is being recorded today, March 31, 2022.
I will now turn the call over to Dr. Kimberly Lee, Chief Corporate Affairs Officer. Please go ahead.
Good morning and welcome to Taysha's Fourth Quarter and Full Year 2021 Financial Results and Update Conference Call. Joining me on today's call are RA Session II, Taysha's President, Founder and CEO; Dr. Suyash Prasad, Chief Medical Officer and Head of R&D; and Kamran Alam, Chief Financial Officer.
After our formal remarks, we will conduct a question-and-answer session, and instructions will follow at that time.
Earlier today, Taysha issued a press release announcing financial results for the fourth quarter and full year ended December 31, 2021. A copy of this press release is available on the company's website and through our SEC filings.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |